The Inhibitory Effects of Juglanin on Adipogenesis in 3T3-L1 Adipocytes

Overview

Journal Drug Des Devel Ther

Specialty Pharmacology

Date 2020 Dec 9

PMID 33293796

Citations 7

Authors

Guang Wang

Bing Wu

Wenzhou Xu

Xuefei Jin

Kun Wang

Heyuan Wang

Affiliations

Soon will be listed here.

Abstract

Introduction: Deregulation of adipogenesis plays an important role in obesity and other metabolism disorders. PPAR, C/EBP and SREBP1c are key transcriptional factors involved in adipogenesis and lipogenesis. Juglanin is a natural compound belonging to flavonoids, and it has been reported that juglanin has a potent inhibitory effect on inflammation and certain type of cancers. However, the effects of juglanin in adipogenesis have not been reported before.

Materials And Methods: 3T3-L1 preadipocytes were incubated with differentiation induction medium in the presence or absence of 0.5, 2.5, or 5 µM juglanin for an 8-day differentiation period. The lipid droplets accumulated in the cytoplasm were monitored by Oil Red O staining on days 0, 2, 5, and 8. The regulatory effects of juglanin on adipogenesis-related genes and proteins were investigated by real-time polymerase chain reaction and Western blot analysis.

Results: Juglanin significantly decreased lipid accumulation in differentiated adipocytes. Our findings show that juglanin reduced the expression of C/EBPα, C/EBPβ, and SREBP-1c without affecting PPARα or PPARγ expression. Additionally, juglanin increased the activation of the SIRT1/AMPK signaling pathway through the phosphorylation of AMPKα. Finally, we performed an AMPK inhibitor experiment, which revealed that the inhibitory effects of juglanin on adipogenesis are mediated through AMPK.

Discussion: Juglanin can prevent adipogenesis by suppressing lipid accumulation and the differentiation of preadipocytes. The mechanism of juglanin regulating adipogenesis requires further investigation. Future clinical study in vivo could shed more light on its implication in modulating obesity and metabolic disorders.

Citing Articles

A Comprehensive Review of Molecular Mechanisms, Pharmacokinetics, Toxicology and Plant Sources of Juglanin: Current Landscape and Future Perspectives.

Rutkowska M, Witek M, Olszewska M Int J Mol Sci. 2024; 25(19).

PMID: 39408653 PMC: 11476773. DOI: 10.3390/ijms251910323.

A.St.-Hil. improves lipid metabolism in high-fat diet-fed obese rats and suppresses intracellular lipid accumulation in 3T3-L1 adipocytes via the AMPK-dependent and insulin signaling pathways.

Kudo M, Gao M, Hayashi M, Kobayashi Y, Yang J, Liu T Food Nutr Res. 2024; 68.

PMID: 38327997 PMC: 10845893. DOI: 10.29219/fnr.v68.10307.

Protopanaxadiol-Enriched Rice Exerted Antiadipogenic Activity during 3T3-L1 Differentiation and Anti-Inflammatory Activity in 3T3-L1 Adipocytes.

Monmai C, Kim J, Sim H, Yun D, Oh S, Rha E Pharmaceutics. 2023; 15(8).

PMID: 37631337 PMC: 10458103. DOI: 10.3390/pharmaceutics15082123.

Alternative Methods as Tools for Obesity Research: In Vitro and In Silico Approaches.

Pamplona J, Zoehler B, Shigunov P, Barison M, Severo V, Erich N Life (Basel). 2023; 13(1).

PMID: 36676057 PMC: 9860640. DOI: 10.3390/life13010108.

Rhododendrol, a reductive metabolite of raspberry ketone, suppresses the differentiation of 3T3‑L1 cells into adipocytes.

Uramaru N, Kawashima A, Osabe M, Higuchi T Mol Med Rep. 2023; 27(2).

PMID: 36633126 PMC: 9879071. DOI: 10.3892/mmr.2023.12938.

References

Moraes-Vieira P, Saghatelian A, Kahn B . GLUT4 Expression in Adipocytes Regulates De Novo Lipogenesis and Levels of a Novel Class of Lipids With Antidiabetic and Anti-inflammatory Effects. Diabetes. 2016; 65(7):1808-15. PMC: 4915575. DOI: 10.2337/db16-0221. View

Park M, Sharma A, Lee H . Anti-Adipogenic Effects of Delphinidin-3---Glucoside in 3T3-L1 Preadipocytes and Primary White Adipocytes. Molecules. 2019; 24(10). PMC: 6571603. DOI: 10.3390/molecules24101848. View

Ferre P, Foufelle F . SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Horm Res. 2007; 68(2):72-82. DOI: 10.1159/000100426. View

Wolins N, Quaynor B, Skinner J, Tzekov A, Park C, Choi K . OP9 mouse stromal cells rapidly differentiate into adipocytes: characterization of a useful new model of adipogenesis. J Lipid Res. 2005; 47(2):450-60. DOI: 10.1194/jlr.D500037-JLR200. View

Heo M, Choung S . Anti-obesity effects of Spirulina maxima in high fat diet induced obese rats via the activation of AMPK pathway and SIRT1. Food Funct. 2018; 9(9):4906-4915. DOI: 10.1039/c8fo00986d. View

Nakae J, Kitamura T, Kitamura Y, Biggs 3rd W, Arden K, Accili D . The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell. 2003; 4(1):119-29. DOI: 10.1016/s1534-5807(02)00401-x. View

Yuen H, Hung A, Yang A, Lenon G . Mechanisms of Action of Cassiae Semen for Weight Management: A Computational Molecular Docking Study of Serotonin Receptor 5-HT2C. Int J Mol Sci. 2020; 21(4). PMC: 7072867. DOI: 10.3390/ijms21041326. View

Suarez E, Bach D, Cadefau J, Palacin M, Zorzano A, Guma A . A novel role of neuregulin in skeletal muscle. Neuregulin stimulates glucose uptake, glucose transporter translocation, and transporter expression in muscle cells. J Biol Chem. 2001; 276(21):18257-64. DOI: 10.1074/jbc.M008100200. View

Lee J, Schmidt H, Lai B, Ge K . Transcriptional and Epigenomic Regulation of Adipogenesis. Mol Cell Biol. 2019; 39(11). PMC: 6517598. DOI: 10.1128/MCB.00601-18. View

10.

Liang Y, Yang M, Lin C, Chang C, Yang W . Bidens pilosa and its active compound inhibit adipogenesis and lipid accumulation via down-modulation of the C/EBP and PPARγ pathways. Sci Rep. 2016; 6:24285. PMC: 4827119. DOI: 10.1038/srep24285. View

11.

Park Y, Obiang-Obounou B, Lee K, Choi J, Jang B . AZD1208, a pan-Pim kinase inhibitor, inhibits adipogenesis and induces lipolysis in 3T3-L1 adipocytes. J Cell Mol Med. 2018; 22(4):2488-2497. PMC: 5867077. DOI: 10.1111/jcmm.13559. View

12.

Lalani S, Poh C . Flavonoids as Antiviral Agents for (). Viruses. 2020; 12(2). PMC: 7077323. DOI: 10.3390/v12020184. View

13.

Liou C, Wu S, Chen L, Yeh K, Chen C, Huang W . Acacetin from Traditionally Used Kar. et Kir. Suppressed Adipogenesis in 3T3-L1 Adipocytes and Attenuated Lipid Accumulation in Obese Mice. Front Pharmacol. 2017; 8:589. PMC: 5581916. DOI: 10.3389/fphar.2017.00589. View

14.

Yang H, Ma Y, Gao C, Wang B, Aruhan , Lin C . Five novel diarylheptanoids from green walnut husks (Juglans regia L.). Fitoterapia. 2019; 134:221-225. DOI: 10.1016/j.fitote.2019.03.002. View

15.

Skinner A, Ravanbakht S, Skelton J, Perrin E, Armstrong S . Prevalence of Obesity and Severe Obesity in US Children, 1999-2016. Pediatrics. 2018; 141(3). PMC: 6109602. DOI: 10.1542/peds.2017-3459. View

16.

Walker A, Yang F, Jiang K, Ji J, Watts J, Purushotham A . Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes Dev. 2010; 24(13):1403-17. PMC: 2895199. DOI: 10.1101/gad.1901210. View

17.

Greenwood-Goodwin M, Teasley E, Heilshorn S . Dual-stage growth factor release within 3D protein-engineered hydrogel niches promotes adipogenesis. Biomater Sci. 2014; 2(11):1627-1639. PMC: 4188404. DOI: 10.1039/C4BM00142G. View

18.

Hossain M, Abdal Dayem A, Han J, Yin Y, Kim K, Saha S . Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids. Int J Mol Sci. 2016; 17(4):569. PMC: 4849025. DOI: 10.3390/ijms17040569. View

19.

Sun Z, Dong J, Wu J . Juglanin induces apoptosis and autophagy in human breast cancer progression via ROS/JNK promotion. Biomed Pharmacother. 2016; 85:303-312. DOI: 10.1016/j.biopha.2016.11.030. View

20.

Delzenne N, Cani P . Interaction between obesity and the gut microbiota: relevance in nutrition. Annu Rev Nutr. 2011; 31:15-31. DOI: 10.1146/annurev-nutr-072610-145146. View